Sort
82,697 grants matching “vaccine development”
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
Characterization of immunogenic and structural properties of HIV-1 envelope
$951,914Michael W Cho · Iowa State University · P01 · FY2012 · AI
Diversity of Host Pathogen Interactions
$951,778Samuel I. Miller · University Of Washington · U54 · FY2013 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$951,702Michael R. Farzan · Scripps Florida · R37 · FY2017 · AI
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
$951,677Lauren Ilyse Richie Ehrlich · University Of Texas At Austin · R01 · FY2021 · AI
Studying factors controlling cancer progression and immune recognition in mouse models
$951,640Tyler E Jacks · Massachusetts Institute Of Technology · R35 · FY2025 · CA
Chlamydial Immunity and Vaccine Development
$951,585Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Cellular Immune Responses to RSV infection in Mice
$951,522Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Coronavirus vaccine development
$951,522Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Role of Gut-Specific Factors in the Control of Regulatory T Cells
$951,510Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Pathogenic determinants of the SIV envelope transmembrane cytoplasmic domain
$951,507James A Hoxie · University Of Pennsylvania · R01 · FY2013 · AI
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$951,462Bryan David Bryson · Massachusetts General Hospital · R01 · FY2022 · AI
Defining Mechanisms of HIV-1 Gag:RNA Interactions and Virus Assembly
$951,445Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
HANTAVIRUS ECOLOGY AND DISEASE IN CHILE AND PANAMA
$951,433Gregory James Mertz · University Of New Mexico · U19 · FY2009 · AI
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
$951,400Charles T Roberts · Oregon Health & Science University · R01 · FY2024 · DK
Universal Attenuated Sporozoite Vaccine and Challenge System
$951,398Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2018 · AI
Does repeated influenza vaccination constrain influenza immune responses and protection?
$951,396Sheena G Sullivan · University Of Melbourne · R01 · FY2021 · AI
SBIR Phase II: Serialized Anti-Counterfeit Labeling Technology for Pharmaceutical and Biological Products
$951,394Brendan G Delacy · Ballydel Technologies Inc. · · FY2024 · TIP
Accelerated molecular probe pipeline
$951,168Gerard A Cangelosi · Seattle Biomedical Research Institute · U01 · FY2011 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$951,064Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AI
Evaluation and Production of a Multivalent Adenoviral Plague Vaccine
$951,043Eric Rothe · Norwell, Inc. · R44 · FY2014 · AI
Plant Viruses as Platforms for Biomaterials
$950,962Scripps Research Institute · R01 · FY2004 · EB
Recombinant Subunit West Nile Virus Vaccine Development
$950,816L2 Diagnostics, Llc · U01 · FY2004 · AI
A Novel, Logical Approach to HIV Vaccine Development
$950,584David I Watkins · University Of Wisconsin-Madison · R01 · FY2006 · AI
Human immune signatures of latent MTB infection, active disease and BCG vaccination
$950,551Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2019 · AI